Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic…
Orphan drug designation by USFDA for ZYIL1 provides eligibility for certain development incentives, including tax credits for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cryopyrin-Associated Periodic Syndrome
Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with…
Cryopyrin-Associated Periodic Syndrome (CAPS) is a rare life-long auto-inflammatory condition, caused by NLRP3 activating…